Maynard Um
-
-
-
-
-
-
-
Repare Therapeutics (RPTX) PT Lowered to $3 at H.C. Wainwright
-
-
-
-
-
-
-
Repare Therapeutics Inc. (RPTX) Provides Business and Clinical Update
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Repare Therapeutics (RPTX)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Repare Therapeutics (RPTX)
-
-
-
-
-
-
-
Repare Therapeutics (RPTX) Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

